CompoAtlas

INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION

Food supplement declared in France, declaration No 2020-4-783

INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION, from BIOGARAN, is a food supplement declared in France. Status: withdrawn from the market on 15 June 2023. Main ingredients: Aesculus hippocastanum 480 mg per day, Ruscus aculeatus 100 mg per day, Aesculus hippocastanum 60 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
INTRAIT MARRON D'INDE
Food business operator placing the product on the market
BIOGARAN
Status
Withdrawn from the market on 15 June 2023
Form
Capsule
Daily dose
DJMR : 4 gélules / jour
Directions for use
1 gélule matin et soir. Si nécessaire, doubler la prise, soit 2 gélules matin et soir.
Not recommended (according to the manufacturer)
Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Blood and lymphatic circulation

Declaration 168431, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Aesculus hippocastanum L.GraineExtrait sec hydroalcoolique480 mg
Ruscus aculeatus L.RhizomeExtrait sec hydroalcoolique100 mg
Aesculus hippocastanum L.EcorceExtrait sec hydroalcoolique60 mg

Additives

E460, E470b, E141, E464

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne peuvent être utilisés comme substituts d’un régime alimentaire varié et équilibré et d’un mode de vie sain. Tenir hors de portée des enfants. Déconseillé aux enfants, aux femmes enceintes et aux personnes sous traitement anti-coagulant.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Aesculus hippocastanum L.
    Read the warning, when it applies and the studies cited

    Horse Chestnut - Aesculus Hippocastanum

    Route of administration: Oral (Bradley 2006; ESCOP 2003)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    When using this product you may experience headache, dizziness, gastric irritation, or itchiness (Bradley 2006; Mills and Bone 2005; ESCOP 2003).

    Sources cited by Health Canada (3)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 27 February 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : INTRAIT MARRON D'INDE

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “INTRAIT MARRON D'INDE JAMBES LEGERES CIRCULATION: composition and regulation”, https://compoatlas.com/en/supplements/products/168431-intrait-marron-d-inde-jambes-legeres-circulation, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line